home / stock / dskyf / dskyf articles

DSKYF Articles, Daiichi Sankyo Co Ltd

Stock Information
Company Name: Daiichi Sankyo Co Ltd
Stock Symbol: DSKYF
Market: OTC
Menu
DSKYF DSKYF Quote DSKYF Short DSKYF News DSKYF Articles DSKYF Message Board
Get DSKYF Alerts

News, Short Squeeze, Breakout and More Instantly...
FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug | Benzinga

On Wednesday, the FDA issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) seeking accelerated approval of Daiichi S...
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More | Benzinga

Biotech stocks are high-risk, high-return opportunities that are under the mercy of several make-or-break catalysts, most of which are binary event...

Why Is AstraZeneca Stock Trading Lower On Tuesday? | Benzinga

On Tuesday, AstraZeneca Plc (NASDAQ:AZN) said the survival results did not reach statistical significance in the overall trial population...

Double Good News For AstraZeneca's Breast Cancer Drugs | Benzinga

AstraZeneca plc (NASDAQ:AZN) reported topline data from a metastatic breast cancer treatment study. The results showed that Enhertu (t...
AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor | Benzinga

On Friday, the FDA approved Daiichi Sankyo Ltd’s (OTC:DSKYF) (OTC:DSNKY) and AstraZeneca Plc’s (NASDAQ:AZN) Enhertu...

What's Going On With Pfizer Stock Today? | Benzinga

Pfizer Inc (NYSE:PFE) is set to announce its fourth quarter 2023 earnings next week on 30th January. The analysts expect the US pharma giant to re...

Merck Signs Multi-Billion Deal With Japan's Daiichi Sankyo For Cancer Therapy Drug Development | Benzinga

Merck & Company, Inc. (NYSE: MRK) and Japan's Daiichi Sankyo Co. Ltd. (OTC: DSKYF) entered into a global developme...
Better Than Chemotherapy - AstraZeneca/Daiichi Sankyo Partnered Cancer Drug Meets Primary Goal In Breast Cancer Setting | Benzinga

AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo (OTC: DSKYF) (OTC: DSNKY) released topline data from the TROPION-Bre...

AstraZeneca's Reinforces Hold In Lung Cancer Settings: Touts Promising Data From Three Trials | Benzinga

Daiichi Sankyo (OTC: DSKYF) (OTC: DSNKY) and AstraZeneca plc (NASDAQ: AZN) released initial results from the TROPION-Lung04 phase 1b...

Next 10